Skip to content

Our Company

Recreating a future for Parkinson's

Who We Are

NeuroDerm is an agile, entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions. By integrating the unique, complementary strengths and diverse capabilities of Pharma and MedTech under one roof, we create synergies and value in the space between existing drugs and innovative treatments and technologies.

We develop next-generation drug-device combination solutions for central nervous system disorders through proprietary drug formulations, state of the art delivery systems and digital health technologies, connecting them all into a comprehensive solution for the benefit of patients and healthcare.

NeuroDerm is an Israel-based, wholly owned subsidiary of Mitsubishi Tanabe Pharma Corporation which, in turn, has global presence in Japan, United States, and Europe.

17

countries having recruiting clinical sites

>80

patents granted in over 15 jurisdictions

60%

of our employees are female

Company Milestones

Meet our team

Our mission

We are driven to reduce disease burden and improve the quality of life of patients and their families, with innovative drug-device combination therapies & technologies.

It’s all about our people

Let's stay in touch

For general inquiries or to learn more about NeuroDerm, please complete the form below. For medical information or to report on your own health or experience, please consult your healthcare provider. Please click here for information about our clinical trials.

*
*
*
*